Recent Finacing
Recent Raise
PathGen develops low-cost PCR-based cancer genetic testing kits compatible with Indonesian lab infrastructure and advances NGS, digital pathology, and AI for improved diagnostics and treatment decisions.
Focus Areas
Recent Investors
Funding round
Investors
See the team members at PathGen Diagnostik Teknologi.